Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody

The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow

(2011) Sheren F. Younes et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL

(2011) Elena Cubedo et al.   FEBS Journal

LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome

(2011) R. Malumbres et al.   HAEMATOLOGICA

Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components

(2010) Sheren F. Younes et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The thymus under siege: Lmo2 induces precancerous stem cells in a mouse model of T-ALL

(2010) Matthew P. McCormack et al.   CELL CYCLE

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

(2010) Paul N. Meyer et al.   JOURNAL OF CLINICAL ONCOLOGY

The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal

(2010) M. P. McCormack et al.   SCIENCE

The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities

(2009) Dita Gratzinger et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Targeting LMO2 with a Peptide Aptamer Establishes a Necessary Function in Overt T-Cell Neoplasia

(2009) A. Appert et al.   CANCER RESEARCH

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

(2009) W. W.L. Choi et al.   CLINICAL CANCER RESEARCH

Regulation of LMO2 mRNA and protein expression in erythroid differentiation

(2009) S. J. Brandt et al.   HAEMATOLOGICA

Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study

(2009) Christiane Copie-Bergman et al.   JOURNAL OF CLINICAL ONCOLOGY

Labeling of Multiple Cell Markers and mRNA Using Automated Apparatus

(2009) Jennifer C. Paterson et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Progenitor migration to the thymus and T cell lineage commitment

(2008) Arivazhagan Sambandam et al.   IMMUNOLOGIC RESEARCH

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

(2008) Steven J. Howe et al.   JOURNAL OF CLINICAL INVESTIGATION

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

(2008) Salima Hacein-Bey-Abina et al.   JOURNAL OF CLINICAL INVESTIGATION

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

(2008) J-P Jais et al.   LEUKEMIA

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions

(2008) C-H Nam et al.   ONCOGENE

The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man

(2008) Daniel A. Zlotoff et al.   Seminars in Immunopathology

LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab

(2007) Yasodha Natkunam et al.   JOURNAL OF CLINICAL ONCOLOGY